Moving Forward with Decentralized Clinical Trials (DCTs) - November 9, 14, & 16, 2023

Don’t miss this opportunity to learn the important considerations for implementing decentralized clinical trials and get the key take-aways from the recently issued FDA Draft Guidance on Decentralized Clinical Trials.

Back to Agenda

Part 1: Introduction to DCTs

Session Chair(s)

Amy Bohn

Director, DCT Operations, DCT Strategy & Implementation

Bayer, United States

Session 1: Welcome and Introduction
Session 2: Introduction to Decentralized Clinical Trials (DCT) and DCT Elements
Session 3: Value of DCTs
Session 4: Technology and Remote Elements in Trials
Session 5: Points to Consider in DCTs
Exercise, Questions and Answers